ABEO: Countdown to PDUFA Date of April 29, 2025
On March 20, 2025, Abeona Therapeutics, Inc. (ABEO) announced financial results for the fourth quarter and full year of 2024 and provided a...
271 Views
ABEO: FDA Accepts BLA Re-Submission for Pz-cel PDUFA Date of April 29
On November 14, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the third quarter of 2024 and provided a business...
208 Views
ABEO: Type A Meeting with FDA Concluded BLA Submission on Track for 2H24
On August 12, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the second quarter of 2024 and provided a business...
214 Views
ABEO: BLA Resubmission in 2H24
On May 15, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2024 and provided a business update. The...
274 Views
Abeona Therapeutics Inc (ABEO) - Thursday, Feb 15, 2024
Abeona is developing a cell therapy for the rare disease RDEB, with FDA review ongoing and a target action date of May 25th
190 Views
No more insights